As diabetes and hypertension were more prevalent in FLD+, they were also statistically significantly more likely to be using angiotensin-converting enzyme inhibitor or angiotensin receptor antagonist or diabetes medication (69.2 vs. 60.2% and 46.6 vs. 20.8%, respectively) (Figure 1 and Table 1). This evidence concerns the gene ACE and Hypertension.